Clinical Trial Update: Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC [Phase 2]

View source ↗

Summary

A Phase 2 single-center trial is evaluating AHCC in combination with standard-of-care therapy for HPV-positive head and neck squamous cell carcinoma; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• AHCC (Active Hexose Correlated Compound)

Snippet

Sponsor: University of California, Irvine | Conditions: HNSCC, Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING